go-v.orgdoi

Prognostic Impact Of P53, EGFR And HER2/Neu Proteins On Renal Cell Carcinoma

KL Relph, A Michael, E Havranek, C Anderson, A Polychronis, C Corbishley, H Pandha · The Internet Journal of Urology · 2006

  • DOI 10.5580/cf5
  • Publisher OpenAlex
  • Type article
  • Issued 2006

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

The Internet Journal of Urology · OpenAlex · article · 2006

Abstract

The expression of p53, HER2/neu and EGFR in renal cell carcinoma was studied using immunohistochemical methods in paraffin-embedded nephrectomy specimens from 40 patients. Expression of p53, EGFR and HER2/neu was observed in 22 (55%), 33 (82.5%) and 10 (25%) patients respectively. In the Cox regression analysis overall expression of p53 was not statistically significant with a p value of 0.5 for total expression, 0.6 for weak expression and 0.2 for strong p53 expression. The HER2 positivity was also not statistically significant with a p value of 0.2 and a hazard ratio of 0.4.

Similar results were obtained for EGFR overexpression with a p value of 0.591 for overall positivity, 0.3 for weak staining and 0.56 for strong staining. Our results indicate that p53, EGFR and HER2/neu proteins may play a role in determining the prognosis in RCC. However the results were insignificant and a greater patient cohort is required before any true conclusions can be made.

Open the resolved locator · 10.5580/cf5

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 00:59 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
http://doi.org/10.5580/cf5
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.